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Abstract
Rationale and Objective A stress-induced increase in excit-
ability can result from a reduction in inhibitory neurotransmis-
sion. Modulation of gamma-aminobutyric acid (GABA)ergic
transmission is an effective treatment for drug seeking and
relapse. This study investigated whether baclofen, a GABAB
receptor agonist, had an impact on morphine-induced condi-
tioned place preference (CPP), extinction, and stress-induced
relapse in chronically stressed mice.
Methods Chronic stress was induced by restraining mice for
2 h for seven consecutive days. We first investigated whether
chronic stress influenced morphine-induced CPP, extinction,
and stress-induced relapse in the stressed mice. Next, we in-
vestigated whether three different doses of baclofen influenced
chronic stress as measured by the expression of morphine-
induced CPP. We chose the most effective dose for subsequent
extinction and reinstatement experiments. Reinstatement of
morphine-induced CPP was induced by a 6-min forced swim
stress. Locomotor activity was also measured for each test.
Results Chronic stress facilitated the expression of morphine-
induced CPP and prolonged extinction time. Forced swim
stress primed the reinstatement of morphine-induced CPP in
mice. Baclofen treatment affected the impact of chronic stress
on different phases of morphine-induced CPP.
Conclusions Our results showed that baclofen antagonized
the effects of chronic stress on morphine-induced CPP.
These findings suggest the potential clinical utility of
GABAB receptor-positive modulators as an anti-addiction
agent in people suffering from chronic stress.
Keywords Addiction . Morphine . Baclofen . Restraint
stress . Forced swim stress . Dose . Schedule . Conditioned
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Introduction
Drug addiction is a global public health concern with major
economic consequences. While moderately effective treat-
ments are available for some addictions, high relapse rates
still occur. Human studies (Gawin and Kleber 1986; Wallace
1989) and experiments with animal models (Barsy et al.
2011; Grakalic et al. 2006; Kreibich et al. 2009) have iden-
tified stress as a critical factor in the drug addiction process,
including triggering relapse. Extensive literature has attrib-
uted actions in the limbic system that in turn influence
motivational, emotional, and affective behaviors, as
reinforcing the effects of drug abuse (Koob 1992; Martin
et al. 2008; Nielsen et al. 2012; Rezayof et al. 2002). All of
these findings suggest that treatment aimed at reducing stress
could be therapeutically effective for drug addiction.
Electrophysiological experiments indicate that stress or
high levels of corticosteroids induce activation of the amyg-
dala, increasing the excitability of principal neurons
(Duvarci and Pare 2007; Roozendaal et al. 2009). This
increase in excitability can also be the result of stress-
induced reduction in inhibitory neurotransmission, which
has been reported in the amygdala (Davis et al. 1994; Feng
et al. 2013) and in the hypothalamus (Verkuyl et al. 2005). In
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addition, gamma-aminobutyric acid (GABA) is the dominat-
ing inhibitory neurotransmitter in the central nervous system
(CNS), and modulation of GABAergic transmission was
effective against drug seeking and relapse (de Guglielmo
et al. 2012; Fattore et al. 2009; Kemppainen et al. 2012;
Pan et al. 2012; Parker et al. 2011). Recent studies have
focused on the role of GABAB receptors in regulating abuse
of drugs such as alcohol (Leggio et al. 2012), nicotine
(Fattore et al. 2009), morphine (Heinrichs et al. 2010), and
cocaine (Halbout et al. 2011).
Baclofen is a lipophilic analog of GABAwith high affin-
ity for the bicuculline-insensitive GABAB receptor (Bowery
1989). Imaging studies indicate that baclofen blunts the
limbic activation associated with visual drug cues in drug-
addicted humans (Brebner et al. 2002). Baclofen also
inhibited the expression of many psychostimulant-induced
behaviors in rodents including conditioned place preference
(CPP) (Li et al. 2001) and self-administration (Brebner et al.
2005; Weerts et al. 2007). Meantime, it has been report-
ed that stress can induce opiate and psychostimulant
reinforcement (Kabbaj et al. 2001; Kreibich et al.
2009; Rozeske et al. 2012). However, little is known
about whether baclofen blocks drug addiction facilitated
by stress.
This study examined if baclofen, a GABAB receptor
agonist, pharmacologically inhibited morphine-induced
CPP and stress-induced relapse in chronically stressed mice.
We used a CPP and extinction/reinstatement model of
morphine-seeking behavior in mice conditioned to mor-
phine. As baclofen can have muscle relaxant and seda-
tive effects, it was tested at doses known to affect
operant response but not spontaneous locomotor activity




Three hundred male adult BALB/c mice aged 5–8 weeks
were obtained from the Laboratory Animal Center of the
Fourth Military Medical University (FMMU). The animals
were housed in plastic boxes in groups of four with food and
water available ad libitum in a colony room with controlled
temperature (24±2 °C), humidity (50–60 %), and a 12/12-h
light/dark cycle. Mice were allowed to adapt to laboratory
conditions for at least 1 week before the procedure.
Experiments were carried out during the light phase of the
cycle. At the beginning of each experiment, there were 10
newmice in each group, and the use of animals was reviewed
and approved by the Institutional Ethical Committee of the
FMMU. In experiment 1, two mice from the stressed and
non-stressed groups treated with morphine were excluded
after post-conditioning (Post-C) 8d because of failure to
express morphine preference, and one mice from non-
stressed group treated with morphine was excluded after
Extinction 10d test because of extinction failure. In experi-
ment 5, one mice from the non-stressed group treated with
morphine was excluded after Post-C 7d, and one mice from
stressed group treated with morphine was excluded after
Extinction 10d test. The whole experiments complied with
the current laws of China.
Drugs
(RS)-Baclofen (Tocris Cookson, Bristol, UK) and morphine
(Shenyang, China) dosages, and the subcutaneous (s.c.)
route of administration (Feng et al. 2011; Heinrichs et al.
2010) were selected based on previous studies showing
efficacy in altering drug reward. Morphine (1 and 3 mg/kg)
was used in experiment 2, and 10 mg/kg morphine was used
in other experiments. Baclofen (BL) was administered in
0.612, 1.25, or 2.5 mg/kg (s.c.). All drugs were dissolved
in a volume of saline corresponding to 0.1 ml/10 g body
weight.
Chronic stress
Chronic stress was induced by restraining the mice in well-
ventilated Perspex restraining tubes for 2 h on seven consec-
utive days, during which the animals were not physically
compressed or experience pain (Chotiwat and Harris 2006).
After restraint, mice returned to their home cages and given
food and water ad libitum. Non-restrained controls were
placed in a Perspex cage in the same experimental room
and experienced a similar degree of daily handling during
the restraining period.
Conditioned place preference apparatus and procedure
CPP was performed in a CPP apparatus with a computer
equipped with an automonitoring system (Jiliang, Shanghai,
China). It consists of two compartments, identical in size
(30×30×40 cm each), separated by a platform with the sides
painted white and black, respectively. General experimental
protocol was adapted from previous studies, with some
modifications. The whole protocol had six different
phases: pretreatment, pre-conditioning test, conditioning,
post-conditioning test, extinction, and reinstatement test;
the total duration of each phase was disparate because
of the different treatments, and the details were shown
in Fig. 1. On each test day, the activity of each animal
was recorded and measured to determine the time spent
on each side of the experimental box when the guillo-
tine doors were raised.
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Pre-conditioning
After receiving the chronic stress, control and restraint mice
were placed in one of the two compartments and allowed
access to explore both environments for 15 min individually.
Time spent in each compartment was automatically
measured by the PC software and the initial preference
or aversion for one side of the two compartments was
determined. Animals spending more than 10 min in a
specific compartment were excluded from the study. All
mice showed a moderate preference for the black com-
partment (501.6±14.3 s, P<0.05 vs. the time spent in
the white side, Student’s t test).
Conditioning
During this period, the doors were closed. Animals received
two s.c. injections per day of either morphine (morning,
starting at 8:00 a.m.) or saline (afternoon, starting at
2:00 p.m.) before placed in the white or black boxes for
30 min. Then, sessions started immediately. Mice in the
control group were injected with saline twice per day and
placed in either a black or a white compartment. After each
session, the subjects returned to their own home cages. In the
experiment 3, each mouse in baclofen-treated groups re-
ceived an additional injection with baclofen (s.c.) 30 min
before morphine treatment.
Post-conditioning
At 24 h after the last morphine treatment, doors were opened
so that animals had access to both compartments for 15 min.
The time spent in each compartment was measured. Only
animals displaying robust morphine CPP (i.e., an increase in
preference for the drug-paired compartment ≥100 s com-
pared to the pre-conditioning test) were used in the subse-
quent phase of the study.
Extinction
At 24 h after the post-conditioning test, mice were given
extinction training daily. The procedure was similar to the
pre-conditioning test. The amount of time that mice spent in
each chamber was determined. Only animals meeting the
criterion of not more than ±20 % of time spent in the drug-
paired compartment during the extinction phase compared to
the pre-conditioning test was used for the next phase. In
experiment 4, each mouse in the baclofen-treated group
received a single injection with baclofen (s.c.) immediately
after extinction training.
Stress-induced reinstatement
After extinction, animals were divided into saline-treated
and baclofen-treated groups. All mice underwent forced
swim stress (FS) as described (Briand et al. 2010). Briefly,
mice were placed for 6 min in plastic cylinders (23 cm
height×14 cm diameter) containing 23–25 °C water that
were 10 cm deep. Following FS, mice were returned to their
home cages 20 min prior to the reinstatement test. Drug or
saline was injected 30 min before FS.
Locomotor activity
On each test day, the total distance traveled by each mouse in
15 min was defined as locomotor activity and determined in
the same apparatus as the CPP procedures. Total distance
traveled in both sides of the apparatus was analyzed using the
automonitoring system.
Statistical analysis
All data were expressed as means±standard error of the
mean (SEM). Statistical significance was determined by
repeated measures ANOVAwith post hoc multiple compar-
































Fig. 1 Experimental design. a This schedule was used for experiments
1–2. On days 1–7, stressed mice underwent 2 h of restraint daily, and
non-stressed mice experienced a similar degree of daily handling but
were not restrained; then in experiment 1, all the mice were tested on
days 8 (Pre-C), 12 (Post-C 4d), 16 (Post-C 8d), 17 (Extinction 1), 20
(Extinction 4), 23 (Extinction 7), and 24 (Reinstatement); in experiment
2, all the mice were tested on days 8 (Pre-C), 12 (Post-C 4d), and 16
(Post-C 8d). b This schedule was used for the stressed mice in exper-
iments 3–5. Stressed mice underwent 2 h of restraint daily on days 1–7,
and then in experiment 2 were tested on days 8 (Pre-C) and 12 (Post-C
4d). In experiment 3, stressed mice were tested on days 8 (Pre-C), 12
(Post-C 4d), and 16 (Extinction 4). In experiment 4, stressed mice were
tested on days 8 (Pre-C), 12 (Post-C 4d), 22 (Extinction 10), and 23
(Reinstatement). c This schedule was used for the non-stressed mice in
experiment 4. After 7 days handling, mice were tested on days 8 (Pre-C),
15 (Post-C 7d), 22 (Extinction 7), and 23 (Reinstatement). During all test
periods, doors were raised, and mice were allowed to explore compart-
ments. Time spent on each side was measured. C, conditioning; d, day
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one-way ANOVAwere used if necessary. In all cases, P<0.05
was considered statistically significant. Calculations were
performed using the SPSS 16.0 statistical package.
Results
Experiment 1: effects of stress on the expression, extinction,
and reinstatement of morphine-induced conditioned place
preference
We first determined whether chronic stress from 2 h of daily
restraint for 7 days affected the expression, extinction, and
reinstatement of 10 mg/ kg morphine-induced CPP. A re-
peated measures ANOVA [between-subjects factors: stress
condition (stress, non-stress), drug (morphine, saline);
within-subjects factor: conditioning day (pre-conditioning
(Pre-C), Post-C 4d, Post-C 8d)] was used. The analysis
revealed a significant effect of stress condition [F(1,
36)=4.98, P<0.05], drug [F(1, 36)=21.43, P<0.01], and
interaction of stress condition, drug, and conditioning day
[F(2, 72)=32.54, P<0.01]. A Newman–Keuls test showed
that only the stressed mice treated with morphine spent
significantly more time on the drug-paired side after three
pairing sessions (P<0.01, Fig. 2a). These results suggested
that after three pairing sessions only the stressed mice ac-
quired morphine-induced CPP. Further test found that the
non-stressed mice also expressed morphine-induced CPP
after three more pairing sessions (P<0.01, Fig. 2a). These
results indicated that the failure on the first test day in these
mice was due to a lacking of pairing time. These data
demonstrated that chronic stress facilitated the expression
of morphine-induced CPP.
Next, the effect of chronic stress on the extinction of
morphine-induced CPP was investigated. Time spent on the
morphine-paired side showed significant differences between
extinction tests (Extinction 1d, 4d, 7d, 10d), compared to Pre-
C test [repeated measures ANOVA, F(1, 34)=9.61, P<0.01,
and significant effects of test, F(4, 136)=3.25, P<0.05; stress
condition, F(1, 34)=4.53, P<0.05; drug, F(1, 34)=4.71,
P<0.05; and interaction of stress condition, drug, and test,
F(4, 136)=3.05, P<0.05; Fig. 2a]. The Newman–Keuls test
revealed that stressed mice spent significantly greater amounts
of time in the morphine-paired chamber at extinction day 7
compared to Pre-C test. This did not happen in the non-
stressed mice or in stressed mice conditioned with saline
(P<0.05, Fig. 2a). Moreover, similar to the mice in other
groups, no significant CPP was induced in the stressed mice
conditioned with morphine after 10 extinction trainings.
These data suggested that chronic stress prolonged the extinc-
tion time of morphine-induced CPP in mice.
It is unknown whether acute FS induced the reinstatement
of stress-facilitated morphine-induced CPP in mice. A re-
peated measures ANOVA [between-subjects factors: stress
condition (stress, non-stress), drug (morphine, saline);
within-subjects factor: test (extinction 10d, reinstatement)]
analysis showed significant effects of drug [F(1, 32)=13.21,
P<0.01], and test [F(1, 32)=9.65, P<0.01], and a statistical
interaction of drug and test, but no effect of stress condition.
Further, Newman–Keuls test found that both stressed and
non-stressed mice treated with morphine spent significantly
more time in the drug-paired side after primed with 6-min
FS, compared to mice in the Extinction 10d test (P<0.01,
Fig. 2a). This result was not seen for saline-treated mice.
Locomotor activity was also measured. The repeated


























































Fig. 2 Effect of stress on expression, extinction, and reinstatement of
morphine-induced conditioned place preference. Animals were condi-
tionedwith 10mg/kgmorphine, and all groups were tested on the schedule
described in Fig. 1. On reinstatement day, mice underwent 6min of forced-
swim stress and were returned to home cages for 20 min before testing.
Data are means±SEM and are as follows: a time in seconds spent in the
drug-paired compartment; b distance traveled inmillimeters during the test
period. N=10 mice per group. *P<0.05, **P<0.01 vs. pre-conditioning
test (Pre-C). ##P<0.01 vs. the last extinction test. ^P<0.05 vs. the corre-
sponding test in non-stressed mice. Sa, saline; Mor, morphine
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condition (stress, non-stress), drug (morphine, saline); within-
subjects factor: test (all the test days)] analysis revealed a
significant effects of stress condition [F(1, 32)=33.21,
P<0.01], but no effect of drug and test. Newman–Keuls test
showed that no groups showed significant differences in dis-
tance traveled in the two chambers during any test period
(Fig. 2b). However, a significant decrease of the distance
traveled was found in the stressed mice, compared with the
non-stressed mice (P<0.05). These results suggested that
chronic stress reduced the locomotor activity of the mice.
Experiment 2: 1 and 3 mg/kg morphine induced morphine
preference in the stressed mice after three pairing sessions
To further confirm the effect of chronic stress on expression
of morphine preference, two lower doses of morphine, 1 and
3 mg/kg, were used. A repeated measures ANOVA [be-
tween-subjects factors: stress condition (stress, non-stress),
drug (saline, 1 mg/kg morphine, 3 mg/kg morphine); within-
subjects factor: conditioning day (Pre-C, Post-C 4d, Post-C
8d)] revealed a significant effect of stress condition [F(1,
54)=5.78, P<0.05], drug [F(2, 54)=12.34, P<0.01], and
interaction of stress condition, drug, and conditioning day
[F(2, 108)=21.56, P<0.01]. A Newman–Keuls test showed
only the stressed mice conditioned with 1 mg/kg, and
3 mg/kg morphine spent significantly more time on the
drug-paired side after three pairing sessions (1 mg/kg mor-
phine, P<0.05; 3 mg/kg morphine, P<0.01, Fig. 3a). After
seven pairing sessions, more place preference also was found
in the non-stressed mice conditioned with 3 mg/kg morphine
(P<0.01, Fig. 3a). All of these data suggested that chronic
stress enhanced the sensitivity to morphine reward in mice.
Moreover, a significant effect of stress condition on loco-
motor activity was found [F(1, 54)=6.51, P<0.05], but no
effect of drug and test. Newman–Keuls test showed a signif-
icant decrease of the distance traveled in the stressed mice,
compared with the non-stressed mice (Fig. 3b).
Experiment 3: baclofen blocked morphine-induced CPP
facilitated by chronic stress
In the following experiments, 10 mg/kg morphine was used
because of the more preference in drug-paired compartment
after three conditioning (1 mg/kg, 489.2±23.6 s; 3 mg/kg,
545.8±30.5 s; 10 mg/kg, 598±23.5 s). Since chronic stress
accelerated the expression of morphine-induced CPP, we then
determined whether BL treatment could inhibit this effect.
Three different doses of BL (0.612, 1.25, and 2.5 mg/kg) were
chosen based on the previous study (Fattore et al. 2009). After
chronic stress for 1 week, the mice were trained as the CPP
procedure. As shown in Fig. 4a, mice that received morphine
for 3 days spent more time in the white compartment, showing
a significant CPP for morphine (P<0.01 vs. pre-conditioning).
A one-way ANOVA analysis [between-subjects factors: drug
(saline, BL 0.612, BL 1.25, BL 2.5, morphine, morphine+BL
0.612, morphine+BL 1.25, morphine+BL 2.5)] revealed that
time spent in the drug-paired side showed no significant
difference in all the saline-treated groups after three condition-
ing sessions (Fig. 4a). However, in the morphine-treated
groups, all three doses of BL, injected 30min beforemorphine
treatment, significantly decreased the time in the morphine-
paired chamber [BL 0.612, F(3, 36)=3.56, P<0.05; BL 1.25,
F(3, 36)=7.26, P<0.01; BL 2.5, F(3, 36)=9.26, P<0.01;
n=10 in each group, Fig. 4a], compared to the mice treated
only with morphine. Moreover, 1.25 and 2.5 mg/kg BL treat-
ment significantly inhibited morphine-induce CPP, but 0.612
BL did not (P<0.01 vs. pre-conditioning). These data dem-
onstrated that 1.25 and 2.5 mg/kg baclofen blocked morphine-
induced CPP facilitated by chronic stress. BL (2.5 mg/kg) was
chosen in the following experiments.
In addition, although chronic stress reduced the distance
traveled by mice in the chambers (Fig. 2b), saline-paired,
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Fig. 3 Effect of two lower doses of morphine on conditioned place
preference in the stressed mice. Morphine (1 and 3 mg/kg) was chosen
here to induce morphine preference, all the mice were tested only on
days 8 (Pre-C), 12 (Post-C 4d), and 16 (Post-C 8d) on the schedule of
Fig. 1a. Data are means±SEM and are as follows: a time in seconds
spent in the drug-paired compartment; b distance traveled in millimeters
during the test period. N=10 mice per group. *P<0.05, **P<0.01 vs.
pre-conditioning test (Pre-C). #P<0.05 vs. the corresponding test in
non-stressed mice. Mor, morphine
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difference in the distance (Fig. 4b), suggesting that the effect
of BL was not due to a change in locomotor activity of mice
after three conditioning sessions.
Experiment 4: baclofen enhanced extinction
of morphine-induced CPP facilitated by chronic stress
In light of the above finding, chronic stress not only impact-
ed the expression of morphine-induced CPP but also slowed
down the extinction, and BL blocked the expression.
Therefore, we wondered whether BL would facilitate the
extinction of morphine-induced CPP. Mice that completed
CPP training were administered with systemic saline or
2.5 mg/kg BL immediately after each extinction training
session. The repeated measures ANOVA [between-subjects
factors: morphine (morphine, saline), drug (BL, saline);
within-subjects factor: test (Pre-C, Post-C 4d, Extinction
4d)] analysis revealed a significant effects of morphine
[F(1, 36) =10.54, P<0.01] and BL [F(1, 36) =4.17,
P<0.05]; the interaction of morphine and BL was also found
[F(1, 36)=7.54, P<0.01]. Newman–Keuls test revealed that
mice receiving saline injection showed no chamber prefer-
ences. However, after three morphine conditioning sessions,
mice expressed place preferences (P<0.01 vs. pre-
conditioning, Fig. 5a). Importantly, in morphine-
conditioned mice, the time spent in the drug-paired side
was significantly different between the saline-treated and
2.5 mg/kg baclofen-treated groups after four extinction train-
ings (P<0.01, Fig. 5a). No morphine preference was seen in
the baclofen-treated group. These data suggested that
2.5 mg/kg baclofen promoted the extinction of morphine-
induced CPP facilitated by chronic stress. Similar to previous
experiments, 2.5 mg/kg baclofen did not affect the distance
traveled by mice (Fig. 5b).
Experiment 5: baclofen prevents stress-induced
reinstatement of morphine place preference in stressed
and non-stressed mice
It has been reported that BL inhibited drug-induced reinstate-
ment of extinguished nicotine-seeking behavior and nicotine
place preference in rodents (Fattore et al. 2009). But it is
unknown whether BL could prevent stress-induced reinstate-
ment of morphine place preference. Based on the results of
experiment 1, here the non-stressed mice received 6
morphine-pairings and 7 extinction trainings, and the
stressed mice received 3 morphine-pairings and 10 extinc-
tion trainings. Then, 2.5 mg/kg BL were injected to the mice
30 min before the FS. Repeated measures ANOVA showed a
significant effect of drug [F(1, 37)=7.85, P<0.01] and test
[F(2, 74)=5.32, P<0.01] in non-stressed mice, and a signif-
icant effect of drug [F(1, 37)=8.02, P<0.01] and test [F(2,
74)=6.21, P<0.01] in stressed mice. Newman–Keuls test
revealed that stressed mice which acquired morphine-
induced CPP did not show chamber preferences after 10
extinction trainings (P<0.01, Fig. 6c), and non-stressed mice
also did not after 7 extinction trainings (P<0.01, Fig. 6a). BL
injection 30 min before FS significantly prevented the rein-
statement of morphine place preference both in stressed
(one-way ANOVA, F(3, 36)=6.74, P<0.01; Newman–
Keuls test, P<0.01, Fig. 6c) and non-stressed mice (one-
way ANOVA, F(3, 36)=5.35, P<0.01; Newman–Keuls test,
P<0.01, Fig. 6a), but saline injection did not. Moreover,
baclofen treatment did not reduce the distance traveled by
mice (Fig. 6b, d), compared with saline injection. Acute FS
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Fig. 4 Effects of baclofen on morphine-induced conditioned place
preference. All mice underwent restraint stress for 1 week and were
tested on days 8 and 12. Three doses of baclofen were used: 0.612, 1.25,
and 2.5 mg/kg. +, mice treated with drug or vehicle; − not treated. Data are
means±SEM and are as follows: a chronic stress as time in seconds spent
in the drug-paired compartment; b locomotor activity as distance traveled
in millimeters during the test period. N=10 mice per group. **P<0.01 vs.
pre-conditioning test (Pre-C). #P<0.05, ##P<0.01 vs. group injected with














































Fig. 5 Effects of baclofen on extinction of morphine-induced CPP and
locomotor activity in stressed mice. After completing CPP training,
extinction was from days 13 to 16. Baclofen was injected (2.5 mg/kg,
s.c.) immediately after each extinction training session. Data are
means±SEM and are as follows: a time (in seconds) spent in the
drug-paired compartment; b distance traveled (in millimeters) during
the test period. N=10 mice per group. **P<0.01 vs. pre-conditioning
test (Pre-C). ##P<0.01 vs. post-conditioning test (Pre-C 4d). BL, bac-
lofen; Sa, saline; Mor, morphine
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Discussion
There has been considerable interest in potential interactions
between exposure to stressors and addiction to drugs. In the
present study, 2 h of restraint stress for seven consecutive
days facilitated the expression of morphine-induced place
preference and inhibited extinction. In addition, we also
found 6-min forced swim stress-reinstated morphine-
induced CPP in the stressed and non-stressed mice.
Baclofen, a GABAB receptor agonist, effectively antago-
nized the impact of chronic stress on morphine addiction,
but did not affect the locomotor activity. Our results sug-
gested the clinical utility possibility of baclofen in
maintaining morphine addicts in a drug-free state.
A great number of studies demonstrate that stress poten-
tiates the reinforcement effects of drugs of abuse (Lu et al.
2003; Rozeske et al. 2011), but the key mechanisms are still
little known. Some evidence supports increased activity in
reward-related brain structures after chronic stress (Correll
et al. 2005; Perrotti et al. 2004). Recently, it has been report-
ed that chronic stress causes amygdala hyperexcitability in
rodents (Rosenkranz et al. 2010). GABA is the dominating
inhibitory neurotransmitter in the CNS, and modulation of
GABAergic transmission has been demonstrated to be effec-
tive on affecting drug seeking and relapse (de Guglielmo
et al. 2012; Fattore et al. 2009; Kemppainen et al. 2012; Pan
et al. 2012; Parker et al. 2011). All of these imply that
augmentation of GABAergic transmission can attenuate the
hyperexcitability caused by chronic stress, further reverse
the vulnerability to drug addiction.
GABAB receptors have been identified in the CNS, where
they provided important inhibitory control of post-synaptic
excitability and presynaptic transmitter release. Post-
synaptically located GABAB receptors activated potassium
conductances, thereby hyperpolarizing neurons (Gahwiler
and Brown 1985; Kaupmann et al. 1998), while pre-
synaptically located GABAB receptors inhibited transmitter
release by inhibiting activation of voltage-gated calcium chan-
nels (Mintz and Bean 1993; Scholz and Miller 1991). In other
words, baclofen treatment can enhance the inhibitory transmis-
sion in the CNS, which may be the underlying mechanism that
baclofen injection after the chronic stress blocked the facilita-
tion of morphine-induced CPP by chronic stress according to
our findings.
The morphine-induced preference in the stressed mice
observed in the current study was highly resistant to extinc-
tion; repeated re-exposure to the chambers over seven extinc-
tion cycles did not extinguish the morphine-induced prefer-
ence in stressed mice, although it did affect non-stressed mice.
We proposed that this likely reflected the increased rewarding
effects of morphine and the strength of the learned association
between morphine-reward and the morphine-paired context
after stress. Baclofen administration immediately after cham-
ber re-exposure inhibited the preference for the morphine-
paired chamber after seven extinction cycles in the stressed
mice. Motor activity was not significantly altered by repeated
baclofen treatment. These findings indicated that augmenting
GABAB receptor signaling facilitated the extinction of
morphine-induced CPP in the stressed mice.
Previous studies support memory acquisition and extinction
can be altered by GABAergic drugs. For example, baclofen
enhanced extinction of opiate and methamphetamine-induced
CPP (Heinrichs et al. 2010; Voigt et al. 2011). Systemic
baclofen enhanced the rate and extent of extinction of condi-
tioned passive avoidance in mice which were demonstrated
learned helplessness (Dubrovina and Zinov’ev 2008). Chronic
stress and re-exposure to cues associated with morphine in-
creased neuronal activity which may reflect hyperresponsive
glutamatergic neurotransmission (Bell et al. 2000; Hotsenpiller
et al. 2001; Rosenkranz et al. 2010). GABAB receptors
inhibited glutamatergic neurotransmission (Lei and McBain
2003; Porter and Nieves 2004). Thus, GABAB receptor acti-
vation is a possible mechanism by which baclofen may pro-







































































































Fig. 6 Effects of baclofen on forced-swim-induced reinstatement of
morphine place preference in stressed and non-stressed mice. a, b Non-
stressed mice were tested on days 8, 16, 23, and 24 (non-stressed
schedule). c, d Stressed mice were tested on days 8, 12, 22, and 23
(stressed schedule). Baclofen was injected (2.5 mg/kg, s.c.) 30 min
before forced swim stress. Data are means±SEM and are as follows:
a, c time (in seconds) spent in the drug-paired compartment; b, d.
distance traveled (in millimeters) during the test period. N=10 mice
per group. **P<0.01 vs. pre-conditioning test (Pre-C). ^^P<0.01 vs.
the last extinction test. ##P<0.01 vs. the group injected only with
morphine. BL, baclofen; Sa, saline; Mor, morphine
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Recently, GABA receptors were investigated for possible
involvement in the resumption of drug use after a drug-free
period. A growing body of studies show the efficacy of
baclofen in reducing reinstatement of cocaine-seeking in-
duced by either a drug priming (Campbell et al. 1999;
Weerts et al. 2007) or a drug-associated cue (Filip and
Frankowska 2007), for example, drug-induced reinstatement
of extinguished nicotine-seeking behavior and nicotine place
preference in rodents (Fattore et al. 2009), as well as cue-
induced reinstatement of alcohol-seeking behavior in alcohol-
preferring lines of rats (Maccioni et al. 2008). For opiates, our
results were consistent with Spano et al. (2007) who reported
that the GABAB receptor agonist baclofen prevented heroin-
induced reinstatement of heroin-seeking behavior in rats.
Both in the stressed and non-stressed mice, baclofen
blocked the effect of forced swim stress on reinstatement of
morphine-induced CPP. This finding suggested that the in-
hibitory effect of baclofen on reinstatement was due to
influence on acute stress. Some evidence suggests that
corticotropin-releasing factor (CRF) was highly co-
expressed with GABAergic neurons in the amygdala (Day
et al. 1999; Veinante et al. 1997). CRF has received extensive
attention as a mediator in maintaining addicted state and
constitutes a prototype for critical important neuropeptide
for addictive processes (Heilig and Koob 2007; Koob and
Volkow 2010; Koob and Zorrilla 2010) and has been impli-
cated in neuroendocrine and behavioral responses to stress
(Britton et al. 1982; Koob and Bloom 1985). CRF was
activated during stress-induced drug reinstatement, where it
facilitated relapse and increases anxiety during acute and
chronic withdrawal (Koob 1999; Shaham et al. 1995). In
addition, stress-induced reinstatement of drug-related
responding in animal models appeared to be dependent on
the activation of both CRF and norepinephrine in elements of
the extended amygdala (Shaham et al. 2000), and signifi-
cantly more CRF mRNA was found in the stress-related
brain regions in rats after exposed to 30 min of restraint
(Babb et al. 2013). Baclofen treatment before the acute stress
enhanced GABAergic transmission in the amygdala at both
pre-and post-synaptic sites, blunting the CRF-mediated ef-
fect, then prevented the reinstatement of morphine-induced
CPP, which was similar to the mechanism of binge ethanol
consumption (Lowery-Gionta et al. 2012).
Although it was reported that exposure to chronic restraint
led to increased novelty-induced locomotor activity (Marin
et al. 2007), and restraint stress induced depressive-like
behavior in the forced swim test and memory impairment
in the object recognition test, without altering locomotor
activity (Budni et al. 2013), Kohler et al. found that chronic
stress rat group showed a significant decrease in motor
activity (Bowman et al. 2002; Kohler and Rauca 1992),
which is consistent with our results. As of this writing, no
clear explanation exists for these differences. However, it
may be possible that the age (young vs. adult animals),
species used (mouse vs. rat), and test procedures (open filed
vs. CPP) contribute to these differences. Reduced locomotor
activity was also observed in rats after chronic forced swim
stress alone, which induced depressive-like behavior.
Some evidence showed that baclofen treatment reduced
morphine maintenance response of self-administration (SA)
in rats (Ramshini et al. 2013; Yoon et al. 2007), and chronic
immobilization stress induced enhancement of opioid SA
(Shaham 1993). However, there are few studies about the
effect of baclofen on stress-induced reinforcement of mor-
phine SA, which should get more attention.
Taken together, our results suggest a powerful effect of
baclofen on blocking the facilitated expression of morphine-
induced CPP by chronic stress, promoting the extinction, and
preventing stress-induced reinstatement of morphine prefer-
ence. Our findings could have implications for the develop-
ment of addiction therapies. Looking to the future, further
studies are required to investigate the molecular mechanisms
underlying the effect of baclofen, in order to find more
positive allosteric modulators of GABAB receptors, which
are able to selectively modify the GABAB receptor function
without side effects.
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